The regulatory framework for pharmaceutical microbiology is at a
crossroads. Novel technologies present challenges when it comes
to their regulation. Cell and gene therapy products. Alternatives
to in vivo testing. Alternatives to the LAL assay. Rapid microbiological
methods. The list goes on.